Sergio Fazio, MD, PhD
Robert Chilton, DO, FACC, FAHA
Grand Rounds: New Data, New Direction...
October 17, 2020
12:45 PM - 01:45 PM CDT
Austin G. Stack, MBBCh, MD, MSc, FASN, FRCPI
Mikhail Kosiborod, MD
Management of Heart Failure: Time to Consider New Options?
Michel Farnier, MD, PhD
Børge G. Nordestgaard, MD, DMSc
Omega-3 Fatty Acids in Patients with ASCVD Risk: The Role of Icosapent Ethyl ...
Christopher P. Cannon, MD
Samuel Dagogo-Jack, MD, DSc
Is It Time to Change Your Treatment Strategy for Type 2 Diabetes Patients wit...
Javed Butler, MD, MPH, MBA
Mr. Jackson Moves to Town: Overcoming Challenges to Optimizing RAASi Therapy
Ewa A. Jankowska, MD, PhD, FESC
Stefan D. Anker, MD, PhD
Beyond Anemia: Understanding the Significance and Treatment of Iron Deficiency
Balancing RAASi Therapy and Potassium: Understanding How it Works
Mechanisms in Heart Failure: Why Iron Deficiency Matters
Robert J. Mentz, MD
Piotr Ponikowski, MD, PHD, FESC, FHFA
Don’t Be Fooled: It’s Not Just Anemia, It’s Iron Deficiency
Practical Considerations to Manage Residual ASCVD Risk
Ileana L. Piña, MD, MPH, FAHA, FACC
Patrick Rossignol, MD, PhD
Potassium Binders in Heart Failure: Who, When, and How
Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
Examining Heart Failure Management: How Can We Do Better?
Prof. Stephen Nicholls
Prof. Kausik Ray
Examining LDL Cholesterol and Our Growing Therapy Options in Primary Prevention
John McMurray, OBE BSc (Hons) MB ChB (Hons) MD FRCP FESC FACC FAHA FRSE FMedSci
Clinical Implications of Heart Failure Trials Presented at the ACC.20/WCC Vir...
Jennifer Caudle, DO
Nicole Bernard Washington, DO, MPH
Taking Care of Yourself While Taking Care of Others During COVID-19
Suneet Mittal, MD FACC FHRS
Aysha Arshad MD, FACC, FHRS, FAHA
Telemedicine During COVID-19 Outbreak
